TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted June 25, 2004
TCL Archive Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge March 27, 1981
